Stock News That Gives You an Edge
Follow us on X for real-time stock news alerts
Stock News
S&P 500
Stock News
S&P 500
Stock News - KalVista Pharmaceuticals, Inc.
$KALV
Latest Stock News for $KALV
KalVista Pharmaceuticals Reports $49.1 Million Revenue for EKTERLY in Transition Period Ending December 31, 2025
Expected Stock impact:
Noticeably Positive
2026-03-25 11:19:44